Home › Funds › Vestal Point Capital, LP › STOK
Vestal Point Capital, LP position in STOK
STOKE THERAPEUTICS INC · Health Care
Vestal Point Capital, LP reported holding 345,000 shares of STOK (STOKE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.0M, representing 0.23% of its reported portfolio and ranking #40 among its reported holdings. Vestal Point Capital, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Vestal Point Capital, LP's STOK position evolved
Vestal Point Capital, LP first disclosed a stake in STOK in Q3 2026 at 345,000 shares (US$9.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 345.00K | $8.97M | New |
About STOK and 13F data
STOK (STOKE THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$146.2M), Lynx1 Capital Management LP (US$101.3M), Redmile Group, LLC (US$100.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STOK
- RTW INVESTMENTS, LP 5.62M sh · $146.21M · Q3 2026
- Lynx1 Capital Management LP 3.90M sh · $101.30M · Q3 2026
- Redmile Group, LLC 3.87M sh · $100.59M · Q3 2026
- BVF INC/IL 3.61M sh · $93.83M · Q3 2026
- Siren, L.L.C. 2.00M sh · $51.88M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.82M sh · $47.41M · Q3 2026
- BAKER BROS. ADVISORS LP 1.31M sh · $34.16M · Q3 2026
- MPM BioImpact LLC 925.13K sh · $24.05M · Q3 2026
- Opaleye Management Inc. 700.00K sh · $22.90M · Q2 2026
- EcoR1 Capital, LLC 835.00K sh · $21.71M · Q3 2026
- Troluce Capital Advisors LLC 806.11K sh · $20.96M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 300.00K sh · $7.80M · Q3 2026
More on Vestal Point Capital, LP
FAQ
How long has Vestal Point Capital, LP held STOK?
Vestal Point Capital, LP has disclosed STOK holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Vestal Point Capital, LP's current position in STOK?
As of Q3 2026, Vestal Point Capital, LP holds 345.00K shares of STOK (STOKE THERAPEUTICS INC), valued at $8.97M, representing 0.23% of its reported portfolio and ranking #40.
Has Vestal Point Capital, LP been buying or selling STOK?
In the latest 13F filing (Q3 2026), Vestal Point Capital, LP newly opened its position in STOK.
Which other funds hold STOK?
Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.